Skip to product information
1 of 1

GeneBio Systems

Recombinant Human IGF-I R/IGF1R (C-6His)

Recombinant Human IGF-I R/IGF1R (C-6His)

SKU:PKSH034014

Regular price $230.40 CAD
Regular price Sale price $230.40 CAD
Sale Sold out
Shipping calculated at checkout.

Size: 50μg

Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Shipping: This product is provided as lyophilized powder which is shipped with ice packs.

Exp date: 12 months

Category ID_II: Recombinant Proteins

Category ID_III: Others

Abbreviation: IGF-I R;IGF1R

Target Synonym: CD221;CD221 antigen;IGF-1R;IGF-I R;IGF-I receptor;IGF-IR;IGF1R;IGFIR;IGFR;JTK13;insulin-like growth factor 1 receptor

Research Areas: Signal Transduction;Cardiovascular;Neuroscience;Cancer;Developmental Biology;metabolism;

Conjugation:

Target Species: Human

Expression Host: HEK293 Cells

Application:

Fusion tag: C-His

UNIProt ID: P08069

Accession: P08069

Background: The insulin-like growth factor-1 receptor (IGF1R) is a transmembrane tyrosine kinase involved in several biological processes including cell proliferation, differentiation, DNA repair, and cell survival. This a disulfide-linked heterotetrameric transmembrane protein consisting of two α and two β subunits, and among which, the α subunit is extracellular while the β subunit has an extracellular domain, a transmembrane domain and a cytoplasmic tyrosine kinase domain. The IGF-I receptor is highly expressed in all cell types and tissues. Essentially all of the biological activities of IGF-I and II have been shown to be mediated via IGF-I R. IGF1R is an important signaling molecule in cancer cells and plays an essential role in the establishment and maintenance of the transformed phenotype. Inhibition of IGF1R signaling thus appears to be a promising strategy to interfere with the growth and survival of cancer cells, is now an attractive anti-cancer treatment target.

Concentration:

Activity: Not validated for activity

Sequence: Glu31-Asn932

Purity: > 95 % as determined by reducing SDS-PAGE.

Formulation: Lyophilized from a 0.2 μm filtered solution of PBS, 1mM EDTA, 0.5% Tween-20, 5% Trehalose, pH 7.4.
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.

Reconstitution: Please refer to the printed manual for detailed information.

Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.

Calculated MW: 103.7&81&22.7 kDa

ObservedMW: 100-130&54 kDa

View full details